Sample Preparation Products for Next Generation Sequencing Market Share [2032]
Sample Preparation Products for Next Generation Sequencing Market Share [2032]
Segments - Sample Preparation Products for Next Generation Sequencing Market by Product Type (Kits, Reagents, Instruments, and Others), Application (Genomics, Transcriptomics, Epigenomics, and Others), End-user (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024-2032
Upcoming
| Report ID :HC-6709
| 4.4 Rating
| 92 Reviews
| 300 Pages
| Format :
Report Description
Sample Preparation Products for Next Generation Sequencing Market Outlook 2032
The sample preparation products for next generation sequencing market size was USD 2.7 Billion in 2023 and is projected to reach USD 8.4 Billion by 2032, expanding at a CAGR of 13.4% during 2024–2032.
The growth of the segment is driven by the need for high-throughput and cost-effective solutions that can accommodate the delicate nature of RNA samples. As research in transcriptomics expands, there is an increasing demand for more streamlined and automated sample preparation solutions, leading to driving the growth of the segment.
Moreover, manufacturers in this segment are focusing on developing high-performance reagents that can minimize the risk of contamination and ensure the stability and integrity of the genetic material during the preparation process. The ongoing development of new reagent formulations and enhancements in existing products to increase efficiency and throughput of NGS workflows continues to boost the growth of the segment.
Sample Preparation Products for Next Generation Sequencing Market Dynamics
Drivers
The expanding applications of NGS across various fields such as clinical diagnostics, drug discovery, and genetic research drives the market. The increasing prevalence of genetic disorders and cancer is particularly significant, as these conditions require precise genomic analysis for diagnosis and treatment planning, thereby boosting the demand for effective sample preparation solutions. Additionally, the ongoing advancements in sequencing technologies and the consequent reduction in the cost of sequencing have made NGS more accessible to a broader range of users, including smaller laboratories and research institutions.
This accessibility increases the volume of genomic data being generated, necessitating robust sample preparation protocols to ensure data quality and reliability. Moreover, the growing emphasis on personalized medicine, which relies heavily on genetic data to tailor therapeutic strategies to individual patients drives the market. As personalized medicine continues to gain traction, the need for high-throughput and accurate sample preparation products escalates, further propelling market growth.
Restraints
The complexity and variability of sample preparation methods, which can lead to inconsistencies in data quality hinders the market. The sensitivity of NGS to sample quality means that minor deviations in sample preparation can significantly impact the results, posing a challenge for standardization across different laboratories and applications.
Additionally, the high cost of advanced sample preparation kits and instruments can be a barrier for smaller laboratories and institutions in developing regions, limiting market penetration. Regulatory challenges also play a role, as the approval process for new sample preparation products can be lengthy and complex, delaying market entry and adoption.
Opportunities
The evolving landscape of genomic research and medicinecreates lucrative opportunities in the market. One of the most promising areas is the integration of artificial intelligence (AI) and machine learning (ML) technologies, which can potentially streamline and optimize the sample preparation process, reducing both time and cost. These technologies can help in automating various steps of sample preparation, enhancing reproducibility and efficiency. The expansion of NGS applications in emerging markets, where increasing healthcare expenditure and growing awareness about genetic diseases are likely to boost the demand for NGS services, including sample preparation.
Additionally, the ongoing development of portable or point-of-care NGS systems offers a unique opportunity for the sample preparation market to develop smaller, more efficient products tailored for these compact systems. The increasing focus on liquid biopsy tests for cancer detection and monitoring opens new avenues for sample preparation products designed specifically for circulating tumor DNA (ctDNA) and other cell-free DNAs, which require highly sensitive and precise preparation methods to ensure accurate sequencing results.
Scope of the Sample Preparation Products for Next Generation Sequencing Market Report
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.
|
Attributes |
Details |
|
Report Title |
Sample Preparation Products for Next Generation Sequencing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2023 |
|
Historic Data |
2017 -2022 |
|
Forecast Period |
2024–2032 |
|
Segmentation |
Product Type (Kits, Reagents, Instruments, and Others), Application (Genomics, Transcriptomics, Epigenomics, and Others), End-user (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, MarketTrends, and Revenue Forecast |
|
Key Players Covered in the Report |
Agilent Technologies, Inc., Thermo Fisher Scientific Inc., PerkinElmer, Inc., F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Covaris, Inc., Illumina, Inc., Oxford Nanopore Technologies Ltd., New England Biolabs, Inc., QIAGEN N.V., Pacific Biosciences of California, Inc., Hamilton Company, Analytik Jena AG, Zymo Research Corporation, Takara Bio Inc., Tecan Group Ltd., and NorgenBiotek Corp. |
Sample Preparation Products for Next Generation Sequencing Market Segment Insights
Type Segment Analysis
The kits segment holds a major share of the market, due to their ability to provide streamlined workflows and reproducible results, which are crucial in high-throughput sequencing environments.These kits are designed to simplify the process of preparing samples for sequencing, ensuring that the DNA or RNA extracted is of high quality and suitable for NGS application.
The growth in the segment is further fueled by the increasing adoption of NGS in clinical diagnostics, research, and drug development, necessitating efficient and reliable sample preparation solutions. As the technology advances and the cost of sequencing decreases, the demand for these kits is expected to rise, further driving the growth of the segment.
The reagents segment is projected to experience significant growth in the market, as it is essential for the various steps involved in preparing samples, including extraction, purification, fragmentation, size selection, and amplification.
The growth of the segment is driven by the expansion of the NGS market, as these consumables are repeatedly used and required in large quantities for sequencing procedures. The increasing number of sequencing projects worldwide, coupled with ongoing research in genomics and molecular biology. High-quality reagents help in achieving more accurate and consistent sequencing results, which is critical for both research and clinical applications.
Application Segment Analysis
The genomics segment holds a major share of the market, owing to the expanding use of NGS in genomic research, which includes whole-genome sequencing, exome sequencing, and targeted sequencing. The increasing demand for personalized medicine and population genomics studies further fuels the need for advanced sample preparation products that can handle complex genomic samples efficiently. Genomics applications require high-quality DNA extraction and purification, which necessitates robust sample preparation kits and reagents specifically designed for genomic DNA.
The demand for genomics-related sample preparation products is also propelled by the declining costs of genomic sequencing, making it more accessible for a broader range of research and clinical applications. As the field of genomics continues to evolve, there is a growing emphasis on developing more automated and integrated systems to streamline the sample preparation process, thereby reducing manual labor and potential errors while increasing throughput.
Transcriptomicssegment is anticipated to expand at a robust growth rate during the projection period, owing to the increasing use of RNA sequencing (RNA-seq) to understand gene expression patterns, discover new genes, and identify regulatory sequences involved in disease processes. Sample preparation for transcriptomics involves the extraction of high-quality RNA, which is more unstable and prone to degradation than DNA. This necessitates the use of specialized reagents and kits designed to preserve RNA integrity and prevent degradation during the preparation process.
The demand for transcriptomics sample preparation products is also supported by advancements in RNA-seq technologies and the growing application of transcriptomics in clinical diagnostics, particularly in cancer and genetic disorders.
End-user Segment Analysis
Academic and research institutes segment dominate the market, due to the extensive use of NGS technologies in various research fields such as genetics, molecular biology, and evolutionary biology. Academic institutions often spearhead the development and testing of new sequencing methodologies, relying heavily on advanced sample preparation products to ensure the accuracy and reliability of their research outcomes.
The demand within this segment is fueled by the need for cost-effective and efficient solutions that can support the high-throughput requirements typical of academic research projects. Additionally, the growth of collaborative research projects and consortia that utilize NGS technologies further amplifies the demand for standardized and scalable sample preparation solutions. Manufacturers and suppliers of NGS sample preparation products often develop partnerships with academic institutions to facilitate the development of tailored solutions that meet the specific needs of the research community, ensuring continued growth and innovation in this segment.
The pharmaceutical and biotechnology companiessegment is projected to experience significant growth in the market, owing to the increasing integration of NGS technologies in drug discovery and development processes, as well as in the genetic screening for therapeutic interventions. Pharma and biotech companies utilize NGS for a variety of applications, including but not limited to, biomarker discovery, pharmacogenomics, and personalized medicine, which require robust sample preparation protocols to ensure high-quality sequencing data.
The demand in this segment is characterized by a need for highly automated, scalable, and reproducible sample preparation solutions that can be seamlessly integrated into the existing workflows of pharmaceutical and biotechnology research. The stringent regulatory requirements in drug development also necessitate the use of standardized and validated sample preparation products that comply with industry standards. As these companies continue to explore the genetic underpinnings of diseases and the corresponding therapeutic responses, the reliance on effective NGS sample preparation products is expected to increase, driving further growth of the segment.
Regional Analysis
North America dominates the sample preparation products for next-generation sequencing market, largely due to the advanced healthcare infrastructure, strong presence of major pharmaceutical and biotechnology companies, and significant investments in research and development activities. The US leads within this region, supported by extensive funding for genomics research from both government bodies, such as the National Institutes of Health (NIH), and private entities.
The high adoption rate of NGS technologies in clinical diagnostics, personalized medicine, and cancer research also drives the demand for sophisticated sample preparation products. The laboratories and research facilities in the region emphasize high-throughput, automation, and integration capabilities in sample preparation to enhance efficiency and throughput, aligning with the rapid pace of technological advancements in sequencing.
The market in the Asia Pacific is experiencing rapid growth, driven by the expanding biotechnology sector, increasing government initiatives in genomics, and rising investments in healthcare infrastructure. Countries such as China, Japan, and South Korea are at the forefront, leveraging their robust technological advancements to enhance genomic research and clinical applications. The market growth in this region is further propelled by the increasing prevalence of genetic disorders and the rising demand for personalized healthcare solutions, which require effective NGS workflows, including efficient sample preparation.
Additionally, the market benefits from improvements in healthcare policies, growing economic conditions, and an increasing number of collaborations between academic institutions and the biopharmaceutical industry, which collectively boost the adoption of NGS technologies. Additionally, the region's focus on agricultural biotechnology and animal genetics also contributes to the demand for NGS sample preparation products.
Segments
The Sample Preparation Products for Next Generation Sequencing Market has been segmented on the basis of
Product Type
- Kits
- Reagents
- Instruments
- Others
Application
- Genomics
- Transcriptomics
- Epigenomics
- Others
End-user
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer, Inc.
- F. Hoffmann-La Roche Ltd.
- Beckman Coulter, Inc.
- Promega Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Covaris, Inc
- Illumina, Inc.
- Oxford Nanopore Technologies Ltd.
- New England Biolabs, Inc.
- QIAGEN N.V.
- Pacific Biosciences of California, Inc.
- Hamilton Company
- Analytik Jena AG
- Zymo Research Corporation
- Takara Bio Inc.
- Tecan Group Ltd.
- NorgenBiotek Corp.
Competitive Landscape
Key players in the sample preparation products for next generation sequencing market are Agilent Technologies, Inc., Thermo Fisher Scientific Inc., PerkinElmer, Inc., F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Covaris, Inc., Illumina, Inc., Oxford Nanopore Technologies Ltd., New England Biolabs, Inc., QIAGEN N.V., Pacific Biosciences of California, Inc., Hamilton Company, Analytik Jena AG, Zymo Research Corporation, Takara Bio Inc., Tecan Group Ltd., and NorgenBiotek Corp.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Sample Preparation Products for Next Generation Sequencing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sample Preparation Products for Next Generation Sequencing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sample Preparation Products for Next Generation Sequencing Market - Supply Chain
4.5. Global Sample Preparation Products for Next Generation Sequencing Market Forecast
4.5.1. Sample Preparation Products for Next Generation Sequencing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sample Preparation Products for Next Generation Sequencing Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Sample Preparation Products for Next Generation Sequencing Market Absolute $ Opportunity
5. Global Sample Preparation Products for Next Generation Sequencing Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Types
5.3.1. Kits Reagents Instruments Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Sample Preparation Products for Next Generation Sequencing Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Applications
6.3.1. Genomics Transcriptomics Epigenomics Others
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Sample Preparation Products for Next Generation Sequencing Market Analysis and Forecast by End Users
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by End Users
7.2.2. Y-o-Y Growth Projections by End Users
7.3. Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by End Users
7.3.1. Academic and Research Institutes Pharmaceutical and Biotechnology Companies Hospitals and Clinics Others
7.4. Absolute $ Opportunity Assessment by End Users
7.5. Market Attractiveness/Growth Potential Analysis by End Users
8. Global Sample Preparation Products for Next Generation Sequencing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sample Preparation Products for Next Generation Sequencing Demand Share Forecast, 2019-2026
9. North America Sample Preparation Products for Next Generation Sequencing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Types
9.4.1. Kits Reagents Instruments Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. North America Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Applications
9.7.1. Genomics Transcriptomics Epigenomics Others
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. North America Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by End Users
9.10.1. Academic and Research Institutes Pharmaceutical and Biotechnology Companies Hospitals and Clinics Others
9.11. Basis Point Share (BPS) Analysis by End Users
9.12. Y-o-Y Growth Projections by End Users
9.13. Market Attractiveness/Growth Potential Analysis
9.13.1. By Country
9.13.2. By Product Type
9.13.3. By Application
9.14. North America Sample Preparation Products for Next Generation Sequencing Demand Share Forecast, 2019-2026
10. Latin America Sample Preparation Products for Next Generation Sequencing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Types
10.4.1. Kits Reagents Instruments Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Latin America Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Applications
10.7.1. Genomics Transcriptomics Epigenomics Others
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Latin America Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by End Users
10.10.1. Academic and Research Institutes Pharmaceutical and Biotechnology Companies Hospitals and Clinics Others
10.11. Basis Point Share (BPS) Analysis by End Users
10.12. Y-o-Y Growth Projections by End Users
10.13. Market Attractiveness/Growth Potential Analysis
10.13.1. By Country
10.13.2. By Product Type
10.13.3. By Application
10.14. Latin America Sample Preparation Products for Next Generation Sequencing Demand Share Forecast, 2019-2026
11. Europe Sample Preparation Products for Next Generation Sequencing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Types
11.4.1. Kits Reagents Instruments Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Europe Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Applications
11.7.1. Genomics Transcriptomics Epigenomics Others
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Europe Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by End Users
11.10.1. Academic and Research Institutes Pharmaceutical and Biotechnology Companies Hospitals and Clinics Others
11.11. Basis Point Share (BPS) Analysis by End Users
11.12. Y-o-Y Growth Projections by End Users
11.13. Market Attractiveness/Growth Potential Analysis
11.13.1. By Country
11.13.2. By Product Type
11.13.3. By Application
11.14. Europe Sample Preparation Products for Next Generation Sequencing Demand Share Forecast, 2019-2026
12. Asia Pacific Sample Preparation Products for Next Generation Sequencing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Types
12.4.1. Kits Reagents Instruments Others
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Asia Pacific Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Applications
12.7.1. Genomics Transcriptomics Epigenomics Others
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Asia Pacific Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by End Users
12.10.1. Academic and Research Institutes Pharmaceutical and Biotechnology Companies Hospitals and Clinics Others
12.11. Basis Point Share (BPS) Analysis by End Users
12.12. Y-o-Y Growth Projections by End Users
12.13. Market Attractiveness/Growth Potential Analysis
12.13.1. By Country
12.13.2. By Product Type
12.13.3. By Application
12.14. Asia Pacific Sample Preparation Products for Next Generation Sequencing Demand Share Forecast, 2019-2026
13. Middle East & Africa Sample Preparation Products for Next Generation Sequencing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Middle East & Africa Average Pricing Analysis
13.2. Middle East & Africa Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Types
13.4.1. Kits Reagents Instruments Others
13.5. Basis Point Share (BPS) Analysis by Types
13.6. Y-o-Y Growth Projections by Types
13.7. Middle East & Africa Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by Applications
13.7.1. Genomics Transcriptomics Epigenomics Others
13.8. Basis Point Share (BPS) Analysis by Applications
13.9. Y-o-Y Growth Projections by Applications
13.10. Middle East & Africa Sample Preparation Products for Next Generation Sequencing Market Size and Volume Forecast by End Users
13.10.1. Academic and Research Institutes Pharmaceutical and Biotechnology Companies Hospitals and Clinics Others
13.11. Basis Point Share (BPS) Analysis by End Users
13.12. Y-o-Y Growth Projections by End Users
13.13. Market Attractiveness/Growth Potential Analysis
13.13.1. By Country
13.13.2. By Product Type
13.13.3. By Application
13.14. Middle East & Africa Sample Preparation Products for Next Generation Sequencing Demand Share Forecast, 2019-2026
14. Competition Landscape
14.1. Global Sample Preparation Products for Next Generation Sequencing Market: Market Share Analysis
14.2. Sample Preparation Products for Next Generation Sequencing Distributors and Customers
14.3. Sample Preparation Products for Next Generation Sequencing Market: Competitive Dashboard
14.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
14.4.1. Agilent Technologies, Inc. Thermo Fisher Scientific Inc. PerkinElmer, Inc. F. Hoffmann-La Roche Ltd. Beckman Coulter, Inc. Promega Corporation Bio-Rad Laboratories, Inc. Merck KGaA Covaris, Inc Illumina, Inc. Oxford Nanopore Technologies Ltd. New England Biolabs, Inc. QIAGEN N.V. Pacific Biosciences of California, Inc. Hamilton Company Analytik Jena AG Zymo Research Corporation Takara Bio Inc. Tecan Group Ltd. NorgenBiotek Corp.
Methodology
Related Reports
Some other reports from this category!
Our Clients
